SEC 13F Intelligence

Aubrey Capital Management Ltd / BSX

Aubrey Capital Management Ltd’s Boston Scientific Corp Position

Does Aubrey Capital Management Ltd own Boston Scientific Corp (BSX)? Not currently — the last reported position was 44.0K shares worth $5M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q2 2025
Shares
44.0K
% of Portfolio
+1.72%
Quarters Held
5
position exited

Position History BSX

Reported value by quarter
Q2 ’24: $3MQ2 ’24Q3 ’24: $4MQ3 ’24Q4 ’24: $5MQ4 ’24Q1 ’25: $4MQ1 ’25Q2 ’25: $5MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202544.0K$5M+1.72%
Q1 202544.0K$4M+1.78%
Q4 202450.6K$5M+1.71%
Q3 202449.2K$4M+1.59%
Q2 202447.6K$3M+1.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aubrey Capital Management Ltd’s full portfolio or all institutional holders of BSX.